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amal Wijesinghe, MD, Ronen Gurvitch, MBBS, Edgar L. W. Tay, MBBS,
hristopher Thompson, MD, John G. Webb, MD
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bjectives This study sought to describe a method of paravalvular leak closure using a purpose-
peciﬁc occlusion device.
ackground Transcatheter closure of paravalvular leaks has been hampered by technical chal-
enges, the limitations of available imaging modalities, and the lack of closure devices speciﬁcally
esigned for this purpose.
ethods Patients with severe symptomatic paravalvular regurgitation at high risk for repeat surgery
nderwent transcatheter leak closure. Both left ventricular puncture and retrograde transfemoral
pproaches were used with ﬂuoroscopic and 3-dimensional transesophageal guidance. A purpose-
peciﬁc occluder (Vascular Plug III, AGA Medical Corp., Plymouth, Minnesota) was used.
esults Five patients with severe prosthetic mitral and aortic paravalvular leaks underwent at-
empted closure. Implantation of the device was successfully accomplished in all. In 1 patient, the
lug interfered with closure of a mechanical valve leaﬂet and was removed and replaced with an
lternate device. Complications included pericardial bleeding in 2 patients with a transapical ap-
roach. There was no procedural mortality. At a median follow-up of 191 days (interquartile range
IQR] 169 to 203 days) all patients were alive. New York Heart Association functional class fell from 4
IQR 3 to 4) to 2 (IQR 2 to 3), hemoglobin rose from 89 g/l (IQR 87 to 108 g/l) to 115 g/l (IQR 104 to
18 g/l), creatinine fell from 109 mol/l (IQR 106 to 132 mol/l) to 89 mol/l (IQR 89 to 126 mol/l).
edian echocardiographic follow-up at 58 days (IQR 56 to 70 days) reported residual regurgitation
o be reduced from grade 4 to grade 2 (IQR 1.5 to 2.25).
onclusions Closure of mitral and aortic prosthetic paravalvular leaks with the Vascular Plug III us-
ng either a transapical (mitral) or a retrograde (aortic) approach appears promising. (J Am Coll
ardiol Intv 2010;3:759–65) © 2010 by the American College of Cardiology Foundation
rom the St. Paul’s Hospital, University of British Columbia, Vancouver, British Columbia, Canada. Dr. Nietlispach receives an
nrestricted educational grant from the Cardiovascular Research Foundation, Basel, Switzerland.anuscript received January 28, 2010; revised manuscript received April 1, 2010, accepted April 4, 2010.
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760aravalvular regurgitation (PVR) after surgical valve re-
lacement may occur when there is an incomplete seal
etween a prosthetic valve and the surrounding cardiac
issue. Typically this is associated with dehiscence of sewing
ing sutures, often precipitated by infection, annular calci-
cation, or technical factors (1–4). Reoperation for PVR is
ssociated with an increased likelihood of a recurrent leak,
orbidity, and mortality (5). Transcatheter closure of para-
alvular leaks has been hampered by technical challenges,
he limitations of available imaging modalities, and the lack
f closure devices specifically designed for this purpose (6).
e describe our initial experience with paravalvular leak
losure using a device specifically designed for this purpose.
n patients with mitral PVR, a transapical approach and
eal-time 3-dimensional (3D) transesophageal echocardiog-
aphy (TEE) was used, whereas in patients with aortic PVR,
retrograde approach with 3D TEE guidance was used.
ethods
atients. Four patients underwent transapical mitral para-
alvular leak closure with 3D TEE guidance and implantation
of a Vascular Plug III occluder
(AGA Medical Corp., Plymouth,
Minnesota). One patient under-
went retrograde transfemoral aor-
tic paravalvular leak closure with
3D TEE guidance and implanta-
tion of a Vascular Plug III oc-
cluder. Median age was 75 years
(interquartile range [IQR] 71 to
81 years); there were 3 women
nd 2 men. Bileaflet mechanical mitral valves (3 St. Jude
edical Inc. [St. Paul, Minnesota] and 1 Carbomedics Inc.
Austin, Texas]) and 1 aortic bioprosthetic valve (Carpentier-
dwards Perimount, Edwards Lifesciences, Irvine, California)
ad been implanted a median of 14 years (IQR 14 to 17 years)
reviously. Two patients had double valve replacement (aortic
nd mitral) at the time of their surgeries. Median number of
horacotomies was 1 (IQR 1 to 2, with a maximum of 4
horacotomies in 1 patient). All patients had severe PVR
ocumented by TEE and all were in atrial fibrillation and on
ong-term anticoagulation. Comorbidities include hyperten-
ion in 4 (80%), dyslipidemia in 3 (60%), diabetes in 2 (40%),
nd renal failure in 4 (80%) patients. The indication for
aravalvular leak closure was severe heart failure in 4 and
nemia in all 5 patients. All patients had been declined as
andidates by at least 2 cardiac surgeons and written, informed
onsent was obtained.
rocedure. The procedure was conducted under general
nesthesia in a hybrid operating room with fluoroscopic and
EE guidance. Antibiotic prophylaxis was administered. In
mitral patients, percutaneous puncture of the left ventric-
bbreviations
nd Acronyms
D  3-dimensional
QR  interquartile range
VR  paravalvular
egurgitation
EE  transesophageal
chocardiographylar apex was performed under TEE and fluoroscopicuidance using a pigtail catheter in the apex as a landmark
Fig. 1), whereas in the other 2 patients with mitral PVR,
he apex was punctured under direct vision through a small
ntercostal incision. After puncture of the left ventricular
pex, a standard J-wire was advanced into the left ventricle
nd the needle was exchanged for a 5-F sheath. Heparin was
dministered to maintain an activated clotting time above
50 s. An angled catheter (Glidecath, Terumo Medical
orp., Somerset, New Jersey) was advanced through the
heath and directed at the regurgitant lesion allowing an
ngled hydrophilic guidewire (Glidewire, Terumo Medical
orp.) to be steered through the defect into the left atrium.
n appropriately sized occluder device (Vascular Plug III)
as introduced either through the standard short 12-cm
ength 6- or 7-F arterial sheath (St. Jude Medical) or a
hrough a longer hydrophilic sheath (Shuttle, Cook Inc.,
loomington, Indiana).
In the patient with aortic PVR, femoral arterial access
as used. The defect was wired using a 6-F multipurpose
uide catheter and an angled hydrophilic guidewire (Glide-
ire). The Vascular Plug III device was deployed through
he guide catheter.
If the device interfered with mobility of the surgically
mplanted valve, it was removed. If regurgitation was not
educed to a moderate range, a second device was im-
lanted. At the completion of the procedure, heparin was
eversed with protamine, and the left ventricular sheath was
emoved. In case of a percutaneous apical puncture, the
uncture site was manually compressed until hemostasis was
chieved. Heparin was started 4 h after hemostasis was
chieved followed by resumption of oral anticoagulation.
Figure 1. Puncture of the Left Ventricular ApexFluoroscopic guidance using a pigtail in the left ventricle as a landmark.
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761ascular Plug III. The Vascular Plug III is an oval-shaped
ense nitinol mesh (Fig. 2). The height of the device is
.5 mm. Various core sizes are available with dimensions
anging from 4 to 14 mm in the long axis and 2 to 5 mm in
he short axis. The core is extended on the inflow and
utflow aspects by 2-mm rims in order to ensure a stable
osition. The 2 smallest devices (4  2 mm and 6  3 mm)
an be deployed through a 4-F sheath (internal diameter:
.065 inches), followed by the 8  4-mm and 10  3-mm
evices that require a 5-F sheath (internal diameter: 0.072
nches). Larger occluders require a 6-F (for the 10  5-mm
evice, internal diameter: 0.072 inches) or a 7-F sheath (for
he 12 3-mm, 12 5-mm, 14 3-mm, and 14 5-mm
evices, respectively; internal diameter: 0.098 inches). If a
uide catheter is used for deployment, the size correspond-
ng to the required internal diameter has to be chosen. As
ith other Amplatzer occluders (AGA Medical Corp.), the
evice is deployed by pulling back the delivery system,
hereby releasing first the distal rim and finally the proximal
im. The device can be retracted as long as the delivery cable
s not unscrewed from the device.
chocardiography. Imaging was performed using an iE33
ltrasound system (Philips Medical Systems, Andover,
assachusetts) with a fully sampled 3D matrix array TEE
ransducer.
In comparison to 2-dimensional TEE imaging, real-time
D TEE gives clear en face views of the mitral valve and
aravalvular structures (7,8). This imaging modality enables
isualization of the size, shape, and number of paravalvular
efects on both real-time 3D volume images and full
olume 3D color Doppler (Fig. 3). Real-time 3D and full
olume 3D color Doppler images also assist in positioning
nd deployment of the device chosen during the procedure.
he 3D imaging provides good spatial resolution for guid-
ng the position of the guidewire and catheter within the
efect (Fig. 4) and for the positioning and deployment of
Figure 2. The New Purpose-Specific Device for Paravalvular Leak Closure
The Amplatzer Vascular Plug III with the extended proximal and distal rims for
transesophageal echocardiography image, and (right) ﬂuoroscopic image.he Vascular Plug III (Figs. 5A and 5B). The full volumeD color Doppler helps define the extent of the regurgitant
et pre- and post-device insertion (Figs. 6A and 6B).
esults
rocedural outcome. Device implantation was successful in
ll patients with a procedural time of 106 min (IQR 93 to
40 min). Fluoroscopy time was relatively short at 15 min
IQR 13 to 20 min) and contrast use relatively low at 25 ml
IQR 20 to 50 ml). Two patients underwent implantation of
occluders. The Vascular Plug III device sizes implanted in
itral position were 8  4 mm (implanted in 1 patient;
mplanted, removed, and replaced by a Duct Occluder
AGA Medical Corp.] in another patient), 10  3 mm (in
patient), 10  5 mm (in 2 patients), and 12  5 mm (in
al ﬁxation in an area with high ﬂow. (Left) Ex vivo, (middle) 3-dimensional
Figure 3. Localization of the Paravalvular Leaks With 3D TEE
Real-time live 3-dimensional (3D) transesophageal echocardiography (TEE)
image of the mitral annulus and mechanical prosthesis en face from the
left atrium in diastole. The paravalvular defect is located along the antero-
lateral border of the prosthesis ring. Ao  aorta; La  left atrialoptimappendage.
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762patient). The Vascular Plug III size used in aortic position
as 10  5 mm. In 1 mitral patient, the initial device was
laced from the apex and a second device was implanted at
he same sitting using a retrograde approach after a failed
ttempt using the apical approach. In another patient, the
eft ventricular retention disk of an 8 4-mm Vascular Plug
II interfered with a prosthetic leaflet and was removed
Fig. 7). Subsequently a 6  4-mm Duct Occluder was
mplanted with its single retention disk within the left
trium thereby avoiding interference. Bleeding complica-
ions occurred in 2 mitral patients. In 1 patient, a localized
ericardial hematoma was treated conservatively. In the
econd patient, a hemothorax prompted a left-sided thora-
otomy to oversew the apical bleeding site. Both bleeding
Figure 4. Procedural Guidance Using Fluoroscopy and 3D TEE
(Left) Fluoroscopic image of a posterior leak wired (red arrow). (Right) Real-t
from the left atrium in diastole. The catheter (yellow arrow) can be seen thro
Abbreviations as in Figure 3.
Figure 5. Positioning and Deployment of the Vascular Plug Using 3D TEE G
(A) Real-time live 3D TEE image of the mitral annulus and mechanical prosthe
through the defect. There are remaining defects anterior and posterior to the
mechanical prosthesis en face after introduction and release of a second Amp
as in Figure 3.omplications were diagnosed on routine post-procedural
chocardiograms that were performed 2 and 48 h after the
rocedure. No complication occurred in the patient with an
ortic paravalvular leak closure. Discharge home was at a
edian of 14 days (IQR 8 to 20 days). Prolonged hospital
tays were mainly due to mobilization problems in a frail
opulation and to the patient that needed surgical repair of
he access site. Residual regurgitation as assessed by TEE
as reduced to mild in 3 patients and trivial in 2 patients
Fig. 8).
ollow-up. At a median follow-up of 191 days (IQR 169 to
03 days) all patients remained alive. New York Heart
ssociation functional class improved from a median of 4
IQR 3 to 4) at baseline to class 2 (IQR 2 to 3). At last
e 3D TEE image of the mitral annulus and mechanical prosthesis en face
e paravalvular defect located along the border of the mitral prosthesis ring.
ce
face from the left atrium after introduction of an Amplatzer occluder device
er (red arrows). (B) Real-time live 3D TEE image of the mitral annulus and
occluder device across the paravalvular defect (yellow arrow). Abbreviationsime liv
ugh thuidan
sis en
occlud
latzer
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763ransthoracic echocardiographic follow-up, at a median of
8 days (IQR 56 to 70 days), residual regurgitation (mitral
egurgitation in 4 patients, aortic regurgitation in 1 patient)
as reportedly reduced from grade 4 at baseline to grade 2
IQR 1.5 to 2.25). Left ventricular ejection fraction was
nchanged (median: 65% [IQR 60% to 70%]). Estimated
ystolic pulmonary arterial pressure by echocardiography was
nchanged (baseline: 48 mm Hg [IQR 43.5 to 58.25 mm Hg],
ollow-up: 42 mm Hg [IQR 33 to 47 mm Hg]). After 191
ays (IQR 169 to 203 days), creatinine fell from 109 mol/l
IQR 106 to 132 mol/l) to 89 mol/l (IQR 89 to 126
mol/l), glomerular filtration rate rose from 45 ml/min (IQR
2 to 46 ml/min) to 54 ml/min (IQR 45 to 71.5 ml/min) and
emoglobin improved from 89 g/l (IQR 87 to 108 g/l) to 115
/l (IQR 104 to 118 g/l). In the 1 patient for whom hemolysis
Figure 6. Quantification of the Severity of Paravalvular Leaks With 3D TEE
(A) Full volume color 3D image showing severe paravalvular regurgitation thro
showing signiﬁcant reduction in the paravalvular leak after the insertion of 2 A
Figure 7. Device Interference With Prosthesis LeafletsInterference of the Amplatzer Vascular Plug III with 1 leaﬂet of the mechanical valveas the main indication for perivalvular leakage closure, no
ore schistocytes were found in the blood and initially elevated
lasma bilirubin and urine urobilinogen levels normalized.
iscussion
he major findings of our work are the promising results of
aravalvular leak closure using the purpose-specific Am-
latzer Vascular Plug III, the simplification of mitral para-
alvular leak closure by a transapical approach, and the
dvantage of using 3D TEE guidance.
Management of severe paravalvular leaks in candidates with
rohibitive surgical risk is challenging, and current American
nd European guidelines do not address this issue (9,10).
he defect seen in Figure 1 during systole. (B) Full volume color 3D image
zer devices. Abbreviations as in Figure 3.ugh t: (left) both leaﬂets closed; (right) posterior leaﬂet does not open properly.
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764Percutaneous paravalvular leak closure is a technically
ifficult procedure with varying success rates around 60% to
0% (11–13). Procedural success is mainly dependent on the
bility to wire the defect and the completeness of defect
cclusion, without interference with the valve leaflets by the
evice chosen. Most leaks are either oval- or crescent-
haped; however, the location and extent of the leaks vary
ndividually and multiple imaging modalities may play a role
6,14–17). Three-dimensional echocardiography appears
articularly useful in this setting.
The oval shape and dimensions of the Amplatzer Vascu-
ar Plug III appear well-suited for paravalvular leak closures.
he relatively small retention rims may be less likely to
nterfere with mechanical valve leaflets than other currently
vailable occluders (18–23). Although, the Amplatzer Duct
ccluder lacks a retention rim on 1 side, this may compro-
ise stability.
The transapical approach to the mitral valve avoids the
eed for a catheter passage across the interatrial septum or
prosthetic aortic valve. Importantly, apical access allows
elatively direct access to the mitral valve over a short,
traight course. In 1 patient, the apical approach for place-
ent of a second device failed, demonstrating that a variety
f approaches may, on occasion, be necessary. The study
opulation is small and does not allow us to draw general
onclusions. Larger studies are therefore needed.
Initial experience with transapical puncture was obtained
Figure 8. Significant Reduction of Mitral Regurgitation
Improvement of mitral regurgitation from severe (A, C) to trivial degree (B, D)uring diagnostic hemodynamic studies in patients with aortic valve pathology, although this is currently rarely used
ther than in patients with double mechanical valves (24).
eportedly, the risks of hemothorax or hemopericardium
ere approximately 5% (25). More recently, transapical
uncture has found favor as access for transcatheter valve
mplantation (26,27) Transapical access can either be via a
ercutaneous puncture or a small intercostal cut-down.
lthough more invasive and complex, a cut-down facilitates
ontrolled closure of the puncture site, possibly reducing
leeding complications. The bleeding complications that
ccurred in our series did not affect the overall success rate
f the procedure, except for a prolonged hospital stay in the
atient in need for surgical repair.
Three-dimensional TEE was particularly helpful to ob-
ain clear relationships between the defect, the guidewire,
nd the catheter. These relationships cannot be obtained as
asily with 2-dimensional TEE or any other imaging
echniques. The full volume 3D color Doppler helps define
he extent of the regurgitant jet pre- and post-device
nsertion, guiding device size and placement.
onclusions
he Amplatzer Vascular Plug III is a promising device
dding to the interventionalists’ armamentarium of paraval-
ular leak closure devices. Three-dimensional TEE guid-
nce of the procedure gave a clear en-face view of the valve
TEE (A, B) and 2-dimensional transesophageal echocardiography (C, D).nd paravalvular structures. This imaging modality was
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765nvaluable for guiding wire position, device delivery and
eployment, assessing residual paravalvular leaks, and pros-
hetic valve function. For mitral paravalvular leaks, a
ransapical procedure is a promising alterative to a retro-
rade or transseptal approach.
eprint requests and correspondence:Dr. John G. Webb, St. Paul’s
ospital, 1081 Burrard Street, Vancouver, British Columbia
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